Xuehai Ou

Personalized nanovaccines from tumor cells: reshaping the microenvironment and defeating heterogeneity

Tumor heterogeneity and an immunosuppressive microenvironment are major obstacles to effective cancer immunotherapy. Personalized nanovaccines derived from autologous tumor cells offer a compelling strategy to overcome these challenges by preserving the full spectrum of patient-s...